Evaluation of the toxicity of Caralluma europaea (CE) extracts and their effects on apoptosis and chemoresistance in pancreatic cancer cells
FEZ Amrati, OHM Elmadbouh, M Chebaibi… - Journal of …, 2023 - Taylor & Francis
Pancreatic adenocarcinoma is a disease with no effective treatment. Chemo-resistance
contributes to the dismal prognosis for patients diagnosed with the disease. This study aims …
contributes to the dismal prognosis for patients diagnosed with the disease. This study aims …
Evaluation of the toxicity of Caralluma europaea (CE) extracts and their effects on apoptosis and chemoresistance in pancreatic cancer cells
FEZ Amrati, OHM Elmadbouh… - Journal of …, 2023 - ingentaconnect.com
Pancreatic adenocarcinoma is a disease with no effective treatment. Chemo-resistance
contributes to the dismal prognosis for patients diagnosed with the disease. This study aims …
contributes to the dismal prognosis for patients diagnosed with the disease. This study aims …
Evaluation of the toxicity of Caralluma europaea (CE) extracts and their effects on apoptosis and chemoresistance in pancreatic cancer cells
FEZ Amrati, OHM Elmadbouh… - Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Pancreatic adenocarcinoma is a disease with no effective treatment. Chemo-resistance
contributes to the dismal prognosis for patients diagnosed with the disease. This study aims …
contributes to the dismal prognosis for patients diagnosed with the disease. This study aims …
Evaluation of the toxicity of Caralluma europaea (CE) extracts and their effects on apoptosis and chemoresistance in pancreatic cancer cells.
FE Amrati, OHM Elmadbouh, M Chebaibi… - … Structure & Dynamics, 2022 - europepmc.org
Pancreatic adenocarcinoma is a disease with no effective treatment. Chemo-resistance
contributes to the dismal prognosis for patients diagnosed with the disease. This study aims …
contributes to the dismal prognosis for patients diagnosed with the disease. This study aims …